Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ECVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 15.94%
December 31, 2025 22.35%
September 30, 2025 24.37%
June 30, 2025 23.52%
March 31, 2025 11.86%
December 31, 2024 27.45%
September 30, 2024 27.95%
June 30, 2024 27.91%
March 31, 2024 22.78%
December 31, 2023 27.37%
September 30, 2023 29.16%
June 30, 2023 31.68%
March 31, 2023 21.04%
December 31, 2022 27.08%
September 30, 2022 27.97%
June 30, 2022 25.41%
March 31, 2022 25.08%
December 31, 2021 30.46%
September 30, 2021 30.07%
June 30, 2021 24.69%
March 31, 2021 22.06%
Date Value
December 31, 2020 28.62%
September 30, 2020 29.94%
June 30, 2020 28.63%
March 31, 2020 28.60%
December 31, 2019 23.25%
September 30, 2019 24.40%
June 30, 2019 24.58%
March 31, 2019 20.03%
December 31, 2018 23.14%
September 30, 2018 23.13%
June 30, 2018 22.95%
March 31, 2018 18.90%
December 31, 2017 23.41%
September 30, 2017 23.86%
June 30, 2017 25.47%
March 31, 2017 23.10%
December 31, 2016 19.17%
September 30, 2016 23.24%
June 30, 2016 20.41%
March 31, 2016 26.07%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Olin Corp. 5.03%
Stepan Co. 10.73%
Ascent Industries Co. 14.05%
Solesence, Inc. 25.75%
BioLargo, Inc. 38.21%